Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 1;41(5):439-444.
doi: 10.1097/INF.0000000000003448.

Economic Evaluation of Universal Varicella Vaccination in Mexico

Affiliations

Economic Evaluation of Universal Varicella Vaccination in Mexico

Enrique Chacon-Cruz et al. Pediatr Infect Dis J. .

Abstract

Background: Universal varicella vaccination has proven to be cost-effective (CE) in countries where implemented. However, this has not been evaluated for Mexico.

Methods: The yearly disease burden (varicella cases/deaths, outpatient visits, and hospitalizations) was derived from Mexican seroprevalence data adjusted to the 2020 population. The yearly economic burden was calculated by combining disease with Mexican unit cost data from both health care and societal perspectives. Four different vaccination strategies were evaluated: (1) 1 dose of varicella vaccine at 1 year old; (2) 2 doses at 1 and 6 years; (3) 1 dose of varicella vaccine at 1 year, and quadrivalent measles-mumps-rubella-varicella vaccine at 6 years; (4) 2 doses of measles-mumps-rubella-varicella vaccine at 1 and 6 years. We developed an economic model for each vaccination strategy where 20 consecutive birth cohorts were simulated. Vaccination impact (number of avoided cases/deaths) was evaluated for a 20-year follow-up period based on vaccine effectiveness (87% and 97.4% for 1 and 2 doses), and assuming a 95% coverage. We estimated annual costs saved, incremental cost-effectiveness ratio, and costs per life year gained.

Results: Avoided cases during the 20-year follow-up with 1, and 2 doses were 20,570,722 and 23,029,751, respectively. Strategies 1 and 2 were found to be cost saving, and strategy 3 to be CE. Strategy 4 was not CE. Strategies 1 and 2 would allow saving annually $53.16 and $34.41 million USD, respectively, to the Mexican society.

Conclusions: Universal varicella vaccination, using 1 dose or 2 doses, would result in a cost-beneficial and CE public health intervention in Mexico.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Total estimated annual economic burden of Varicella in Mexico (expressed in US dollars).
FIGURE 2.
FIGURE 2.
Costs per LYG: costs from SOC (indirect and direct costs) and HC (only direct costs) perspectives. Vaccination strategies 3 and 4 (95% vaccination coverage). Expressed in US dollars. GDP indicates gross domestic product; HC, healthcare; LYG, life year gained; SOC, society.

References

    1. Meyer PA, Seward JF, Jumaan AO, et al. . Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis. 2000;182:383–390. - PubMed
    1. Aebi C, Ahmed A, Ramilo O. Bacterial complications of primary varicella in children. Clin Infect Dis. 1996;23:698–705. - PubMed
    1. Chacon-Cruz E, Lopatynsky-Reyes E, Lopez-Martinez DA, et al. . Varicella hospitaizations and community-acquired Staphylococcus aureus infection: seven years of active surveillance. Ann Clin Lab Res. 2021; 9:354.
    1. Pinchinat S, Cebrián-Cuenca AM, Bricout H, et al. . Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13:170. - PMC - PubMed
    1. World Health Organization. Summary of WHO position papers—Recommended Immunizations for Children [WHO website]. September 2020. Available at: https://www.who.int/immunization/policy/Immunization_routine_table 2.pdf. Accessed August 4, 2021.

Substances